Related Experiment Video
Updated: Mar 18, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Hypercoagulable Workup in Cryptogenic Stroke: What to Test, and When
Saman Zafar1, Sushma Helagalli Paramashivaiah1, Aparna Prabhu1
1Department of Neurology, Jefferson Einstein Philadelphia Hospital, Philadelphia, PA, USA.
Abstract:
There is a significant percentage of ischemic strokes, particularly in younger people, with etiologies that remain elusive despite standard workup. One dilemma in managing such patients is deciding whether they may have an underlying hypercoagulable condition that would lead to consideration of anticoagulation. Previous guidelines have focused on primary thrombophilia, but acquired conditions exceed genetic causes, and a stepwise approach to exclude such conditions before pursuing primary thrombophilia testing is important to improve diagnostic accuracy. To date, we have not encountered any algorithm in the medical literature that advises exclusion of secondary prothrombotic states prior to considering primary hypercoagulable disorders. This report proposes a methodical approach to screening the basic stroke workup for acquired hypercoagulable states before consideration of primary thromboembolic conditions. These recommendations are informed by the authors' experience at tertiary stroke centers and the current literature.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Coagulation

